Tambocor Tablet

Tambocor Tablet

flecainide

Manufacturer:

iNova

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Flecainide acetate
Indications/Uses
AV nodal reciprocating tachycardia, arrhythmias associated w/ Wolff-Parkinson-White syndrome & similar conditions w/ accessory pathway. Paroxysmal atrial fibrillation in patients w/ disabling symptoms. Arrhythmias of recent onset will respond more readily. Symptomatic sustained ventricular tachycardia. Premature ventricular contractions &/or non-sustained ventricular tachycardia which are causing disabling symptoms, where these are resistant to other therapy or when other treatment has not been tolerated. Maintenance of normal rhythm following conversion by other means.
Dosage/Direction for Use
Supraventricular arrhythmias 50 mg bd, if required may be increased to a max of 300 mg daily. Ventricular arrhythmias Initially 100 mg bd, max: 400 mg/day. Recommended to progressively adjust to the lowest level which maintains arrhythmia control, after 3-5 days. Dosage may be reduced during long-term treatment.
Administration
May be taken with or without food.
Contraindications
Cardiac failure, patient w/ history of MI who has either asymptomatic ventricular ectopics or non-sustained ventricular tachycardia. Long standing atrial fibrillation w/ no attempt to convert to sinus rhythm, haemodynamically significant valvular heart disease. Sinus nodal dysfunction, atrial conduction defects, 2nd degree or greater AV block, bundle branch block or distal block unless pacing rescue available.
Special Precautions
Prior electrolyte disturbances, significant hepatic impairment, patient & w/ permanent pacemakers or temporary pacing electrodes; predisposition to cardiac failure. Patient w/ acute onset of atrial fibrillation following cardiac surgery.
Adverse Reactions
Most commonly, giddiness, dizziness, light-headedness, visual disturbances, nausea & vomiting. Proarrhythmia may occur in patients w/ structural heart disease &/or significant left ventricular impairment.
Drug Interactions
May cause rise in plasma digoxin. Possible additive negative inotropic effects of β-blockers & other cardiac depressants. Enzyme inducers enhance elimination. Reduce flecainide dosage by 50% when given w/ amiodarone.
MIMS Class
ATC Classification
C01BC04 - flecainide ; Belongs to class Ic antiarrhythmics.
Presentation/Packing
Form
Tambocor Tablet 100 mg
Packing/Price
60's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in